Works matching IS 09024441 AND DT 2020 AND VI 105 AND IP 2
Results: 15
R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 223, doi. 10.1111/ejh.13429
- By:
- Publication type:
- Article
Treatment of transfusion‐dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha‐2a.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 216, doi. 10.1111/ejh.13428
- By:
- Publication type:
- Article
Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 203, doi. 10.1111/ejh.13427
- By:
- Publication type:
- Article
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real‐life outcomes of daratumumab treatment.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 196, doi. 10.1111/ejh.13426
- By:
- Publication type:
- Article
Osteoclast stimulatory transmembrane protein (OC‐STAMP) is a promising molecular prognostic indicator for multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 185, doi. 10.1111/ejh.13425
- By:
- Publication type:
- Article
Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 148, doi. 10.1111/ejh.13418
- By:
- Publication type:
- Article
Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 103, doi. 10.1111/ejh.13423
- By:
- Publication type:
- Article
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 231, doi. 10.1111/ejh.13422
- By:
- Publication type:
- Article
BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 164, doi. 10.1111/ejh.13420
- By:
- Publication type:
- Article
Thioredoxin‐1 as a biological predictive marker for selecting diffuse large B‐cell lymphoma patients for etoposide‐containing treatment.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 156, doi. 10.1111/ejh.13419
- By:
- Publication type:
- Article
Prevalence of pyruvate kinase deficiency: A systematic literature review.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 173, doi. 10.1111/ejh.13424
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 126, doi. 10.1111/ejh.13416
- By:
- Publication type:
- Article
First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 116, doi. 10.1111/ejh.13409
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 101, doi. 10.1111/ejh.13258
- Publication type:
- Article